SHANGHAIÂ and HONG KONG, Aug. 24, 2026 /PRNewswire/ --Â Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies, today announced that the Phase I ATTRACT study of our proprietary ATG-201, a CD19/CD3 bispecific T-cell engager antibody for B cell-related autoimmune diseases, has received approval from the Human Research Ethics Committee (HREC) in Australia, and completed the Clinical Trial Notification (CTN) process with the Therapeutic Goods Administration (TGA).

kA 4=2DDlQAC?E2=QmkDEC@?8mp%v\a_` :D 2 rs`h E2C86E:?8 3:DA64:7:4 %rt :?4@CA@C2E:?8 DE6C:4 9:?5C2?46 >2D<:?8 E649?@=@8J[ 56D:8?65 E@ 6=:>:?2E6 rs`h\6IAC6DD:?8 q 46==D]k^DEC@?8m %9:D 3:DA64:7:4 :?E6C24E:@? H:E9 % 2?5 q 46==D E9C@F89 rsb 2?5 rs`h 92D 56>@?DEC2E65 A@E6?E:2= :? EC62E:?8 q 46==\5C:G6? 5:D62D6D 3J =6G6C28:?8 E96 3@5JVD @H? :>>F?6 DJDE6> 7@C AC64:D6 2?5 A@E6?E 24E:@?]k^Am
kA 4=2DDlQAC?E2=Qm%9:D :D 2 !92D6 x 4=:?:42= DEF5J 56D:8?65 E@ 6G2=F2E6 E96 D276EJ[ E@=6C23:=:EJ 2?5 AC6=:>:?2CJ 677:424J @7 p%v\a_` >@?@E96C2AJ :? 25F=E A2E:6?ED H:E9 q 46== C6=2E65 2FE@:>>F?6 5:D62D6D] %96 DEF5J H:== 4@?D:DE @7 EH@ A92D6Di 5@D6 6D42=2E:@? 2?5 5@D6 6IA2?D:@?] %96 AC:>2CJ @3;64E:G6D @7 E96 DEF5J 2C6 E@ 6G2=F2E6 E96 D276EJ 2?5 E@=6C23:=:EJ @7 p%v\a_` >@?@E96C2AJ 2?5 E@ 56E6C>:?6 :ED C64@>>6?565 !92D6 xx 5@D6 W#!asX] $64@?52CJ @3;64E:G6D :?4=F56 6G2=F2E:?8 E96 A92C>24@<:?6E:4 W!zX 2?5 A92C>24@5J?2>:4 W!sX AC@7:=6D[ :>>F?@86?:4:EJ[ AC6=:>:?2CJ 677:424J @7 p%v\a_`]k^Am
kA 4=2DDlQAC?E2=Qmp?E6?86?6 2?5 &rq 92G6 6?E6C65 :?E@ 2? 28C66>6?E E92E 8C2?ED &rq H@C=5H:56 6I4=FD:G6 C:89ED E@ 7FCE96C 56G6=@A[ >2?F724EFC6[ 2?5 4@>>6C4:2=:K6 p%v\a_`[ 2?5 2446DD E@ :ED 2DD@4:2E65 >2?F724EFC:?8 E649?@=@8J :? C6=2E:@? E@ p%v\a_`] p?E6?86?6 H:== 4@?5F4E E96 A92D6 x 4=:?:42= EC:2=D :? r9:?2 2?5 pFDEC2=:2]k^Am
kA 4=2DDlQAC?E2=QmkDEC@?8m%96 4=:?:42= EC:2= 2AAC@G2= :? pFDEC2=:2[ 7@==@H:?8 E96 4=62C2?46 @7 p%v\a_`VD 4=:?:42= EC:2= 2AA=:42E:@? 3J r9:?2VD }|!pk^DEC@?8m kDEC@?8m:? yF?6 E9:D J62C[k^DEC@?8m >2C<D 2? :>A@CE2?E 25G2?46>6?E :? p?E6?86?6VD >F=E:\C68:@?2= 56G6=@A>6?E DEC2E68J 7@C p%v\a_`] %@86E96C[ E96D6 >:=6DE@?6D 56>@?DEC2E6 p?E6?86?6VD 23:=:EJ E@ 6I64FE6 677:4:6?E=J 24C@DD <6J 4=:?:42= >2C<6ED 2?5 C67=64E E96 4@>A2?JVD 7@CH2C5\=@@<:?8 2AAC@249 E@ 3F:=5:?8 p%v\a_` :?E@ 2 A@E6?E:2= 8=@32= AC@8C2> 7@C q 46==\C6=2E65 2FE@:>>F?6 5:D62D6D] pD p?E6?86?6 4@?E:?F6D E@ 6IA2?5 :ED :??@G2E:@? 7@4FD 36J@?5 @?4@=@8J 2?5 96>2E@=@8J :?E@ 2FE@:>>F?6 5:D62D6D[ E96 4@>A2?J C6>2:?D 4@>>:EE65 E@ 255C6DD:?8 2C62D @7 D:8?:7:42?E F?>6E >65:42= ?665 2?5 E@ 56G6=@A:?8 5:776C6?E:2E65[ A@E6?E:2==J 7:CDE\:?\4=2DD 2?5^@C 36DE\:?\4=2DD E96C2A:6D 7@C A2E:6?ED H@C=5H:56]k^Am
kAmkDEC@?8mp3@FE p?E6?86?6k^DEC@?8mk^Am
kA 4=2DDlQAC?E2=Qmp?E6?86?6 r@CA@C2E:@? {:>:E65 WkDEC@?8mQp?E6?86?6Qk^DEC@?8m[ $twzi ehhe]wzX :D 2 8=@32=[ #U2>Ajs\5C:G6?[ 4@>>6C4:2=\DE286 3:@E649 4@>A2?J 7@4FD65 @? 56G6=@A:?8 7:CDE\:?\4=2DD^36DE\:?\4=2DD E96C2A6FE:4D 7@C 5:D62D6D H:E9 D:8?:7:42?E F?>6E >65:42= ?665D] xED A:A6=:?6 DA2?D 7C@> AC64=:?:42= E@ 4@>>6C4:2= DE286D[ H:E9 <6J :?G6DE:82E:@?2= 42?5:52E6D :?4=F5:?8 p%v\_aa Wr{s}`g]a psrX[ p%v\_bf W@C2= rsfb :?9:3:E@CX[ p%v\`_` W!s\{` I c\`qq 3:DA64:7:4 2?E:3@5JX[ p%v\`ad Wqf\wb × !s\{` 3:DA64:7:4 psrX[ p%v\a_f Wαrsb\%vu\β 3:7F?4E:@?2= 7FD:@? AC@E6:?X[ 2D H6== 2D % 46== 6?8286C W%rtX AC@8C2>D 56G6=@A65 FD:?8 p?E6?86?6VD AC@AC:6E2CJ p?%6?v286C® A=2E7@C>]k^Am
kA 4=2DDlQAC?E2=Qmp?%6?v286CkDFAm®k^DFAm[ :D p?E6?86?6VD AC@AC:6E2CJ %rt a]_ A=2E7@C>[ 762EFC:?8 QaZ`Q 3:G2=6?E 3:?5:?8 7@C =@H 6IAC6DD:?8 E2C86ED[ DE6C:4 9:?5C2?46 >2D<:?8[ 2?5 AC@AC:6E2CJ rsb D6BF6?46D H:E9 72DE @?^@77 <:?6E:4D E@ >:?:>:K6 4JE@<:?6 C6=62D6 DJ?5C@>6 Wr#$X 2?5 6?92?46 677:424J] %96D6 492C24E6C:DE:4D DFAA@CE E96 A=2E7@C>VD 3C@25 2AA=:423:=:EJ 24C@DD 2FE@:>>F?6 5:D62D6[ D@=:5 EF>@CD 2?5 96>2E@=@8:42= >2=:8?2?4:6D[ H:E9 AC@8C2>D E2C86E:?8 rs`h I rsb Wp%v\a_` 7@C q 46==\C6=2E65 2FE@:>>F?6 5:D62D6Dj A2CE?6C65 H:E9 &rqX[ rswe I rsb Wp%v\`_e 7@C @G2C:2? 42?46C 2?5 <:5?6J 42?46Cj A2CE?6C65 H:E9 za %96C2A6FE:4D 6DE23=:D965 3J |!| q:@x>A24EX[ p{!!{a I rsb Wp%v\``a 7@C 8J?64@=@8:42= EF>@CD[ 5:86DE:G6 DJDE6> >2=:8?2?4:6D[ 3=2556C 42?46C 2?5 }$r{rX[ {*eves I rsb Wp%v\``_ 7@C >:4C@D2E6==:E6\DE23=6 4@=@C64E2= 42?46CX[ v!#rds I rsb Wp%v\_a` 7@C >F=E:A=6 >J6=@>2X[ {x{#qc I rsb Wp%v\`_a 7@C 24FE6 >J6=@:5 =6F<6>:2 2?5 49C@?:4 >J6=@>@?@4JE:4 =6F<6>:2X 2?5 u{%b I rsb Wp%v\`_f 7@C 24FE6 >J6=@:5 =6F<6>:2X]k^Am
kA 4=2DDlQAC?E2=Qm%@ 52E6[ p?E6?86?6 92D @3E2:?65 bc :?G6DE:82E:@?2= ?6H 5CF8 Wx}sX 2AAC@G2=D :? E96 &]$] 2?5 pD:2[ 2?5 @3E2:?65 ?6H 5CF8 2AA=:42E:@? W}spX 2AAC@G2=D :? `_ pD:2 !24:7:4 >2C<6ED] xED =625 4@>>6C4:2= 2DD6E[ )!~'x~kDFAm®k^DFAm WD6=:?6I@CX[ :D 2AAC@G65 :? E96 |2:?=2?5 @7 r9:?2[ %2:H2? r9:?2[ w@?8 z@?8 r9:?2[ |242F r9:?2[ $@FE9 z@C62[ $:?82A@C6[ |2=2JD:2[ %92:=2?5[ x?5@?6D:2 2?5 pFDEC2=:2[ 2?5 92D 366? :?4=F565 :? E96 ?2E:@?2= :?DFC2?46 D496>6D :? 7:G6 @7 E96D6 >2C<6ED W|2:?=2?5 @7 r9:?2[ %2:H2? r9:?2[ pFDEC2=:2[ $@FE9 z@C62 2?5 $:?82A@C6X]k^Am
kAmkDEC@?8mu@CH2C5\=@@<:?8 DE2E6>6?EDk^DEC@?8mk^Am
kA 4=2DDlQAC?E2=Qm%96 7@CH2C5\=@@<:?8 DE2E6>6?ED >256 :? E9:D 2CE:4=6 C6=2E6 @?=J E@ E96 6G6?ED @C :?7@C>2E:@? 2D @7 E96 52E6 @? H9:49 E96 DE2E6>6?ED 2C6 >256 :? E9:D 2CE:4=6] tI46AE 2D C6BF:C65 3J =2H[ H6 F?56CE2<6 ?@ @3=:82E:@? E@ FA52E6 @C C6G:D6 AF3=:4=J 2?J 7@CH2C5\=@@<:?8 DE2E6>6?ED[ H96E96C 2D 2 C6DF=E @7 ?6H :?7@C>2E:@?[ 7FEFC6 6G6?ED @C @E96CH:D6[ 27E6C E96 52E6 @? H9:49 E96 DE2E6>6?ED 2C6 >256 @C E@ C67=64E E96 @44FCC6?46 @7 F?2?E:4:A2E65 6G6?ED] *@F D9@F=5 C625 E9:D 2CE:4=6 4@>A=6E6=J 2?5 H:E9 E96 F?56CDE2?5:?8 E92E @FC 24EF2= 7FEFC6 C6DF=ED @C A6C7@C>2?46 >2J 36 >2E6C:2==J 5:776C6?E 7C@> H92E H6 6IA64E] x? E9:D 2CE:4=6[ DE2E6>6?ED @7[ @C C676C6?46D E@[ @FC :?E6?E:@?D @C E9@D6 @7 2?J @7 @FC s:C64E@CD @C @FC r@>A2?J 2C6 >256 2D @7 E96 52E6 @7 E9:D 2CE:4=6] p?J @7 E96D6 :?E6?E:@?D >2J 2=E6C :? =:89E @7 7FEFC6 56G6=@A>6?E] u@C 2 7FCE96C 5:D4FDD:@? @7 E96D6 2?5 @E96C 724E@CD E92E 4@F=5 42FD6 7FEFC6 C6DF=ED E@ 5:776C >2E6C:2==J 7C@> 2?J 7@CH2C5\=@@<:?8 DE2E6>6?E[ A=62D6 D66 E96 @E96C C:D<D 2?5 F?46CE2:?E:6D 56D4C:365 :? E96 r@>A2?JVD p??F2= #6A@CE 7@C E96 J62C 6?565 s646>36C b`[ a_ad[ 2?5 E96 5@4F>6?ED DF3D6BF6?E=J DF3>:EE65 E@ E96 w@?8 z@?8 $E@4< tI492?86]k^Am
kAmu@C >@C6 :?7@C>2E:@?[ A=62D6 4@?E24Eik^Am
kAm!# ^ x# r@?E24EDi k^Am
kAm!6E6C ":2?k^Am
kAmt\>2:=i k2 9C67lQ>2:=E@iA6E6C]B:2?o2?E6?86?6]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmA6E6C]B:2?o2?E6?86?6]4@>k^2mk^Am
kAmqs r@?E24EDik^Am
kAmpC:6= vF@k^Am
kAmt\>2:=i k2 9C67lQ>2:=E@i2C:6=]8F@o2?E6?86?6]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm2C:6=]8F@o2?E6?86?6]4@>k^2mk^Am
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?lr}b`hhgU2>AjD5la_ae\_g\acQ ^m ':6H @C:8:?2= 4@?E6?E E@ 5@H?=@25 >F=E:>65:2ik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^2?E6?86?6\C646:G6D\4=:?:42=\EC:2=\2AAC@G2=\:?\2FDEC2=:2\7@C\A92D6\:\2EEC24E\DEF5J\@7\2E8\a_`\45`h\I\45b\E46\:?\3\46==\C6=2E65\2FE@:>>F?6\5:D62D6D\b_agdg`bf]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^2?E6?86?6\C646:G6D\4=:?:42=\EC:2=\2AAC@G2=\:?\2FDEC2=:2\7@C\A92D6\:\2EEC24E\DEF5J\@7\2E8\a_`\45`h\I\45b\E46\:?\3\46==\C6=2E65\2FE@:>>F?6\5:D62D6D\b_agdg`bf]9E>=k^2mk^Am
kAm$~&#rt p?E6?86?6 r@CA@C2E:@? {:>:E65k^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lr}b`hhgU2>Aj%C2?D>:DD:@?0x5la_ae_gaca_b_!#0}t($0&$!#00000r}b`hhgU2>Ajs2E6x5la_ae_gacQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am

